1
Disclosures
Feb 4, 2026 — Mar 25, 2026
Date Range
PRIME
Market Segment

Disclosures

DateTypeHeadlinePDF
Mar 25 Other KYORIN Pharmaceutical: KYORIN Pharma Secures Exclusive Rights to Sell Tuberculosis Drug in Japan PDF

Disclosure Types

Other: 1